| 000 | 01713nam##2200253za#4500 |
|---|---|
| 001 | 9.700313 |
| 003 | CaOODSP |
| 005 | 20210625000759 |
| 007 | cr ||||||||||| |
| 008 | 150407|2015||||xxc|||||o f|0| 0 eng|d |
| 020 | |a978-1-100-25657-3 |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aEn14-210/2015E-PDF |
| 110 | 1 |aCanada. |bEnvironment Canada. |
| 245 | 10|aScreening assessment - twenty-three substances on the domestic substances list used primarily as pharmaceuticals / |h[electronic resource]|c[co-published with] Health Canada. |
| 260 | |aOttawa - Ontario : |bEnvironment Canada |cFebruary 2015. |
| 300 | |a53p.|breferences, tables |
| 500 | |a"Chemical Abstracts Service Registry Numbers 50-06-6 (Phenobarbital), 81-81-2 (Warfarin), 7481-89-2 (Zalcitabine), 50-18-0 (Cyclophosphamide), 126-07-8 (Griseofulvin), 13010-47-4 (Lomustine), 55-86-7 (Mechlorethamine), 148-82-3 (Melphalan), 18883-66-4 (Streptozocin), 55-98-1 (Busulfan), 154-93-8 (Carmustine), 20830-81-3 (Daunorubicin), 56-75-7 (Chloramphenicol), 305-03-3 (Chlorambucil), 29767-20-2 (Teniposide), 57-41-0 (Phenytoin), 443-48-1 (Metronidazole), 30516-87-1 (Zidovudine), 68-22-4 (Norethindrone), 446-86-6 (Azathioprine), 51264-14-3 (Amsacrine), 71-58-9 (Medroxyprogesterone), 604-75-1 (Oxazepam)" |
| 590 | |a15-09|b2015-02-27 |
| 690 | 07|aChemicals|2gcpds |
| 690 | 07|aPharmaceutical industry|2gcpds |
| 775 | 08|tÉvaluation préalable - 23 substances figurant sur la Liste intérieure des substances et utilisées principalement comme produits pharmaceutiques / |w(CaOODSP)9.644209 |
| 856 | 40|ahttp://publications.gc.ca|qPDF|s439 KB|uhttps://publications.gc.ca/collections/collection_2015/ec/En14-210-2015-eng.pdf |